CP

Caligan Partners Portfolio holdings

AUM $1.09B
1-Year Est. Return 521.75%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+521.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.09B
AUM Growth
+$372M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
25
New
Increased
Reduced
Closed

Top Buys

1
+$76.2M
2
+$32.1M
3
+$20M
4
MAZE
Maze Therapeutics
MAZE
+$18.9M
5
VOR icon
Vor Biopharma
VOR
+$17.2M

Top Sells

1
+$39.7M
2
+$25.4M
3
+$20.4M
4
AURA icon
Aura Biosciences
AURA
+$1.4M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LQDA icon
1
Liquidia Corp
LQDA
$3.48B
$280M 25.63%
8,118,892
ABVX
2
Abivax
ABVX
$9.53B
$196M 17.92%
1,451,924
RVMD icon
3
Revolution Medicines
RVMD
$31B
$102M 9.36%
1,283,900
+219,651
MLYS icon
4
Mineralys Therapeutics
MLYS
$2.52B
$101M 9.21%
2,772,654
PCVX icon
5
Vaxcyte
PCVX
$8.97B
$78.7M 7.2%
+1,704,815
EXEL icon
6
Exelixis
EXEL
$11.4B
$68.1M 6.23%
1,553,262
+27,532
ADMA icon
7
ADMA Biologics
ADMA
$2.56B
$54.9M 5.03%
3,012,508
+375,899
TNGX icon
8
Tango Therapeutics
TNGX
$3.8B
$33M 3.03%
+3,729,895
INBX icon
9
Inhibrx
INBX
$1.29B
$25.6M 2.34%
323,565
+87,182
TYRA icon
10
Tyra Biosciences
TYRA
$1.92B
$24.8M 2.27%
944,257
+247,432
XENE icon
11
Xenon Pharmaceuticals
XENE
$5.7B
$24.6M 2.26%
549,665
+105,100
MAZE
12
Maze Therapeutics
MAZE
$1.4B
$22.8M 2.09%
+550,191
RAPT
13
DELISTED
RAPT Therapeutics
RAPT
$21.8M 2%
+644,400
AVTX icon
14
Avalo Therapeutics
AVTX
$329M
$16M 1.47%
881,533
+48,200
ANIK icon
15
Anika Therapeutics
ANIK
$214M
$13.8M 1.26%
1,435,130
VOR icon
16
Vor Biopharma
VOR
$810M
$9.96M 0.91%
+925,067
IVA
17
Inventiva
IVA
$1.18B
$9.3M 0.85%
+2,000,000
VRCA icon
18
Verrica Pharmaceuticals
VRCA
$109M
$7.68M 0.7%
923,910
SPRB
19
Spruce Biosciences, Inc. Common Stock
SPRB
$96.5M
$1.79M 0.16%
+20,514
ELDN icon
20
Eledon Pharmaceuticals
ELDN
$302M
$840K 0.08%
+555,978
AGIO icon
21
Agios Pharmaceuticals
AGIO
$2.06B
– –
-1,131,205
AURA icon
22
Aura Biosciences
AURA
$468M
– –
-227,174
EOLS icon
23
Evolus
EOLS
$305M
– –
-4,138,943
MRUS
24
DELISTED
Merus
MRUS
– –
-216,954
SLS icon
25
SELLAS Life Sciences
SLS
$937M
– –
0